ArticleBMC neurology2026
Construction and verification of multimodal model for prognosis in elderly patients with aneurysmal subarachnoid hemorrhage.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveThis study aimed to construct and validate an individualized prediction model for poor prognosis in elderly patients with Aneurysmal subarachnoid hemorrhage (aSAH) based on multimodal indicators such as clinical, imaging, and laboratory data.
methodsWe retrospectively enrolled 241 consecutive patients with aSAH from January 2017 to December 2020 as the training set. An independent temporal validation set included 104 consecutive patients from January to September 2024, with assignment strictly by chronological order. In the training set, univariate analysis identified candidate predictors of poor prognosis, which were refined via LASSO regression. Significant variables were then entered into multivariate logistic regression to define independent predictors. Using these predictors, we constructed random forest (RF), support vector machine (SVM), and k-nearest neighbor models (KNN). Model performance was assessed using the area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis (DCA). Model interpretability and variable contributions were analyzed with SHapley Additive exPlanations (SHAP).
resultsThere were no statistically significant differences in the baseline clinical data between the training set and the validation set (all P > 0.05). The results of multivariate Logistic regression analysis showed that World Federation of Neurosurgical Societies (WFNS) score, modified Fisher grade, intracerebral hematoma volume, maximum thickness of subarachnoid blood clots, C-reactive protein, and duration of symptomatic cerebral vasospasm were identified as independent risk factors for poor prognosis (all P < 0.05). The performance evaluation of the machine-learning models showed that the SVM model had the best discrimination, with AUCs of 0.838 (95% CI: 0.764-0.912) and 0.791 (95% CI: 0.688-0.895) in the training set and the validation set, respectively. The calibration curve showed a high consistency between the predicted probability and the actual risk. DCA indicated that the model had clinical net benefits within a wide range of thresholds. SHAP analysis confirmed that C-reactive protein, maximum thickness of subarachnoid clot, and intracerebral hematoma volume were the most important contributing factors to the increased risk of poor prognosis.
conclusionThis study successfully constructed and validated a prediction model for poor prognosis in elderly patients with aSAH based on multimodal indicators. The model has robust performance, clinically accessible indicators, and good interpretability, providing a valuable quantitative tool for dynamic risk stratification and implementation of stratified management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.